Skip to main content
    H

    Healthpeak Properties Inc (DOC)

    Official site

    REAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE

    $19.84
    -0.14 (-0.70%)

    Market Cap: $13.23B

    Last updated: Nov 17, 2026 at 4:40 PM ET

    Healthpeak Properties Inc (DOC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Healthpeak Properties (DOC) has a market cap of $13.23B and a P/FFO of 11.1x on its 2026 FFO estimate. Its return on invested capital of 0.70% compares with a 4.25% median across 12 similar companies. Its dividend yield is 6.15%.

    Total Valuation

    Enterprise value is 67.04% above the market cap, as debt exceeds cash.

    Market Cap$13.23B
    Enterprise Value$22.10B
    Latest price (Nov 17, 2026)$19.84

    Key Dates

    The next earnings report is expected on Feb 1, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 18, 2026.

    Next Earnings DateFeb 1, 2027 (expected)
    Last Earnings DateAug 4, 2026
    Next Ex-Dividend DateDec 18, 2026
    Next Payment DateDec 30, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 0.05% in the quarter ended Sep 30, 2026 and shrank 0.71% a year over 2 years.

    Shares Outstanding689.51M
    Shares Change (YoY)-0.78%
    Shares Change (QoQ)-0.05%
    Share Count Growth (2Y CAGR)-0.71%

    Valuation Ratios

    P/FFO is 11.1x on the 2026 FFO estimate of $1.79 a share. Its year-end P/S ranged from 4.4x to 41.9x from 2016 to 2025.

    P/FFO (2026 estimate)11.1x
    P/E Ratio30.1x
    Forward P/E55.3x
    P/S Ratio5.0x
    Forward P/S4.5x
    P/B Ratio1.7x
    P/TBV Ratio2.0x
    P/FCF Ratio12.3x
    P/OCF Ratio10.4x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 19.6x EBITDA and 20.3x free cash flow.

    EV / Earnings52.4x
    EV / Sales8.1x
    EV / EBITDA19.6x
    EV / FCF20.3x

    Price Statistics

    The stock is up 16.72% over 52 weeks and trades 1.74% above its 50-day average.

    Beta (1Y)0.36
    52-Week Change+16.72%
    1-Month Change+5.64%
    3-Month Change-1.41%
    6-Month Change+3.79%
    5-Year Change-46.41%
    10-Year Change-44.44%
    Total Return (1Y)+23.90%
    Total Return (3Y CAGR)+10.61%
    Total Return (5Y CAGR)-6.71%
    Return vs SPY (1Y)+3.30%
    Max Drawdown (1Y)-18.12%
    Max Drawdown (3Y)-28.60%
    Sharpe Ratio (1Y)0.49
    Correlation with SPY (1Y)0.17
    50-Day Average$19.50
    200-Day Average$18.90
    52-Week Range$14.96 to $22.72
    RSI (14 Days)53.9
    Average Volume (20 Days)6.10M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Total debt is 1.19x shareholder equity.

    Debt / Equity1.19x
    Debt / EBITDA8.15x
    Debt / FCF8.46x
    Interest Coverage0.36x

    Returns and Efficiency

    Return on invested capital is 0.70% over the last 12 months, against a 5-year average of 1.12%.

    Return on Equity (ROE)5.36%
    Return on Assets (ROA)1.88%
    Return on Invested Capital (ROIC)0.70%
    ROE (5Y Average)5.13%
    ROA (5Y Average)2.14%
    ROIC (5Y Average)1.12%
    Asset Turnover0.13x

    Taxes

    Income tax took 1.49% of pretax income over the last 12 months.

    Income Tax (TTM)$6.17M
    Effective Tax Rate1.49%

    Scores

    DOC has a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    FFO per share was $1.77 for 2025, the latest reported year. Revenue of $2.72B over the last 12 months is up 8.57% from the 12 months before.

    FFO Per Share (2025)$1.77
    Revenue$2.72B
    Revenue Growth (YoY)+8.57%
    Pretax Income$414.32M
    Net Income$421.38M
    EBITDA$1.15B
    Reported EPS (TTM)$0.66

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 35.12% of the $22.41B in total assets.

    Cash and Equivalents$514.31M
    Total Debt$9.38B
    Net Debt$8.87B
    Net Debt Per Share$12.86
    Shareholder Equity$7.87B
    Book Value Per Share$11.41
    Tangible Book Value$6.88B
    Tangible Book Per Share$9.98
    Total Assets$22.41B
    Total Liabilities$11.61B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $161.50M of capital spending, operating cash flow left $1.11B of free cash flow.

    Operating Cash Flow$1.27B
    Capital Expenditures$161.50M
    Free Cash Flow$1.11B
    FCF Per Share$1.61
    Depreciation and Amortization$1.24B
    Dividends Paid$844.40M
    Share Repurchases$101.75M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    Pretax Margin15.23%
    Net Margin15.49%
    EBITDA Margin42.30%
    FCF Margin40.76%
    Gross Margin (5Y Average)57.00%
    Operating Margin (5Y Average)20.29%
    Net Margin (5Y Average)17.91%

    Growth

    FFO per share grew 3.21% a year over 3 years, and revenue 10.06% a year.

    FFO Per Share Growth (3Y CAGR)+3.21%
    Revenue Growth (3Y CAGR)+10.06%
    Revenue Growth (5Y CAGR)+12.03%
    EPS Growth (3Y CAGR)-51.00%
    EPS Growth (5Y CAGR)-35.20%
    FCF Growth (3Y CAGR)+12.19%
    FCF Growth (5Y CAGR)+10.97%
    Operating Income Growth (3Y CAGR)+15.13%
    Book Value Per Share Growth (2Y CAGR)-3.63%
    Tangible Book Per Share Growth (2Y CAGR)-6.04%

    Revenue and profit by year

    Dividends and Yields

    DOC pays out 68.93% of 2025 FFO as dividends.

    Dividend Per Share (Annual)$1.22
    Dividend Yield6.15%
    Payment ScheduleMonthly
    Dividend Growth (3Y CAGR)+6.86%
    Dividend Growth (5Y CAGR)-3.79%
    Payout Ratio (2025 FFO)68.93%
    FCF Payout Ratio76.14%
    FFO Yield (2025)8.92%
    FCF Yield8.11%
    Buyback Yield0.73%
    Shareholder Yield6.90%

    Full dividend history

    Stock Splits

    The last split was a 2-for-1 forward split on Mar 2, 2004.

    Last Split DateMar 2, 2004
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 12 similar companies, DOC has the 10th highest P/FFO and the 10th highest P/S.

    P/FFO11.1x vs 13.0x median
    P/S Ratio5.0x vs 6.1x median
    ROIC0.70% vs 4.25% median
    Revenue Growth (Trailing 4 Quarters, YoY)+8.57% vs +21.75% median
    Dividend Yield6.15% vs 5.40% median

    Competitors compared

    Analyst Forecast

    FFO per share estimates imply 2.23% growth a year over the next 2 years. Consensus estimates put revenue growth at 11.90% a year over the next 2 fiscal years.

    FFO Per Share Growth Forecast (2Y CAGR)+2.23%
    Revenue Growth Forecast (2Y CAGR)+11.90%
    EPS Growth Forecast (2Y CAGR)+87.08%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About DOC

    What is DOC's market cap?

    Healthpeak Properties has a market cap of $13.23B. Its enterprise value, which adds debt and subtracts cash, is $22.10B.

    What is DOC's P/E ratio?

    Healthpeak Properties has a P/FFO of 11.1x on its 2026 FFO estimate. Its trailing P/E ratio is 30.1x and its forward P/E is 55.3x.

    How many shares of DOC are outstanding?

    Healthpeak Properties has 689.51M shares outstanding. The count is down 0.78% from a year earlier.

    Does DOC pay a dividend?

    Yes. Healthpeak Properties pays $1.22 a share a year, a dividend yield of 6.15%.

    How much debt does DOC have?

    Healthpeak Properties has $9.38B of total debt and $514.31M of cash and equivalents, a net debt position of $8.87B.